Of course they are, and in doing so, they're just behaving rationally, and they do this in every country that tries to introduce reforms to try to contain pharmaceutical expenditures. It's just the nature of the game.
Again, Dr. Levine made this point in his opening remarks. We are never going to get an industry sector to sign on to changes that will result in their revenues coming down. I keep using the analogy with people that, for five years, we've been asking somebody if they want a haircut and they keep telling us no, and then we keep asking them, “Would you like your bangs cut shorter and a little shorter in the back?” They don't want a haircut, right?
You can consult until the cows come home, but you're never going to get industry to back changes to a regulatory regime that are going to result in less revenue for them. The bottom line is that you have to have a fair process and a transparent process. That's what we think we've managed to do.